These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31151913)

  • 1. Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.
    Wu NC; Lv H; Thompson AJ; Wu DC; Ng WWS; Kadam RU; Lin CW; Nycholat CM; McBride R; Liang W; Paulson JC; Mok CKP; Wilson IA
    Cell Host Microbe; 2019 Jun; 25(6):836-844.e5. PubMed ID: 31151913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
    Wu NC; Zost SJ; Thompson AJ; Oyen D; Nycholat CM; McBride R; Paulson JC; Hensley SE; Wilson IA
    PLoS Pathog; 2017 Oct; 13(10):e1006682. PubMed ID: 29059230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution.
    Liang W; Tan TJC; Wang Y; Lv H; Sun Y; Bruzzone R; Mok CKP; Wu NC
    PLoS Pathog; 2022 Sep; 18(9):e1010875. PubMed ID: 36155668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
    J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.
    Hartgroves LC; Koudstaal W; McLeod C; Moncorgé O; Thompson CI; Ellis J; Bull C; Havenga MJ; Goudsmit J; Barclay WS
    Vaccine; 2010 Apr; 28(17):2973-9. PubMed ID: 20188682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity.
    Barman S; Franks J; Turner JC; Yoon SW; Webster RG; Webby RJ
    Vaccine; 2015 Jun; 33(28):3186-92. PubMed ID: 25999284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.
    Li Y; Bostick DL; Sullivan CB; Myers JL; Griesemer SB; Stgeorge K; Plotkin JB; Hensley SE
    J Virol; 2013 Sep; 87(17):9904-10. PubMed ID: 23824816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
    Galli C; Orsi A; Pariani E; Lai PL; Guarona G; Pellegrinelli L; Ebranati E; Icardi G; Panatto D
    Expert Rev Vaccines; 2020 Jan; 19(1):115-122. PubMed ID: 31875483
    [No Abstract]   [Full Text] [Related]  

  • 12. Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.
    Wu NC; Xie J; Zheng T; Nycholat CM; Grande G; Paulson JC; Lerner RA; Wilson IA
    Cell Host Microbe; 2017 Jun; 21(6):742-753.e8. PubMed ID: 28618270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
    Wang W; Alvarado-Facundo E; Vassell R; Collins L; Colombo RE; Ganesan A; Geaney C; Hrncir D; Lalani T; Markelz AE; Maves RC; McClenathan B; Mende K; Richard SA; Schofield C; Seshadri S; Spooner C; Utz GC; Warkentien TE; Levine M; Coles CL; Burgess TH; Eichelberger M; Weiss CD
    Clin Infect Dis; 2021 Dec; 73(11):e4312-e4320. PubMed ID: 32898271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.
    Nakowitsch S; Waltenberger AM; Wressnigg N; Ferstl N; Triendl A; Kiefmann B; Montomoli E; Lapini G; Sergeeva M; Muster T; Romanova JR
    Biotechnol J; 2014 Mar; 9(3):405-14. PubMed ID: 24323790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs.
    Lu B; Zhou H; Chan W; Kemble G; Jin H
    Vaccine; 2006 Nov; 24(44-46):6691-3. PubMed ID: 16814431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
    Gouma S; Furey C; Santos JJS; Parkhouse K; Weirick M; Muramatsu H; Pardi N; Fan SHY; Weissman D; Hensley SE
    J Virol; 2023 Jan; 97(1):e0172322. PubMed ID: 36533954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.
    Nakowitsch S; Wolschek M; Morokutti A; Ruthsatz T; Krenn BM; Ferko B; Ferstl N; Triendl A; Muster T; Egorov A; Romanova J
    Vaccine; 2011 Apr; 29(19):3517-24. PubMed ID: 21406268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.